List of bibliographic references
Number of relevant bibliographic references: 5.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 4 | Breast Neoplasms (drug therapy) |
| 4 | Breast Neoplasms (pathology) |
| 4 | Chemotherapy, Adjuvant |
| 4 | Female |
| 4 | Humans |
| 4 | Middle Aged |
| 3 | Adult |
| 3 | Aged |
| 3 | Breast Neoplasms (mortality) |
| 3 | Disease-Free Survival |
| 3 | Proportional Hazards Models |
| 3 | Receptor, ErbB-2 (metabolism) |
| 3 | Treatment Outcome |
| 2 | Aged, 80 and over |
| 2 | Antineoplastic Agents (therapeutic use) |
| 2 | Breast Neoplasms (enzymology) |
| 2 | Follow-Up Studies |
| 2 | Kaplan-Meier Estimate |
| 2 | Neoplasm Recurrence, Local |
| 2 | Neoplasm Staging |
| 2 | Quinazolines (therapeutic use) |
| 2 | Receptor, ErbB-2 (antagonists & inhibitors) |
| 2 | Receptor, ErbB-2 (genetics) |
| 1 | Antineoplastic Agents (adverse effects) |
| 1 | Antineoplastic Combined Chemotherapy Protocols (administration & dosage) |
| 1 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
| 1 | Breast Neoplasms (genetics) |
| 1 | Breast Neoplasms (metabolism) |
| 1 | Breast Neoplasms (surgery) |
| 1 | Dose-Response Relationship, Drug |
| 1 | Double-Blind Method |
| 1 | Drug Administration Schedule |
| 1 | In Situ Hybridization, Fluorescence |
| 1 | Internationality |
| 1 | Mastectomy (methods) |
| 1 | Molecular Targeted Therapy |
| 1 | Neoplasm Invasiveness (pathology) |
| 1 | Patient Selection |
| 1 | Precision Medicine |
| 1 | Prognosis |
| 1 | Protein Kinase Inhibitors (adverse effects) |
| 1 | Protein Kinase Inhibitors (therapeutic use) |
| 1 | Quality of Life |
| 1 | Quinazolines (adverse effects) |
| 1 | Quinolines (administration & dosage) |
| 1 | Quinolines (adverse effects) |
| 1 | Receptor, ErbB-2 (biosynthesis) |
| 1 | Receptors, Estrogen (metabolism) |
| 1 | Receptors, Progesterone (metabolism) |
| 1 | Signal Transduction (drug effects) |
| 1 | Surveys and Questionnaires |
| 1 | Survival Analysis |
| 1 | Time Factors |
| 1 | Trastuzumab (administration & dosage) |
| 1 | Trastuzumab (adverse effects) |
| 1 | Young Adult |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "Beverly Moy"
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i \
-Sk "Beverly Moy" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Canada
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Beverly Moy
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
